檢索結果 - Tim Mant

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Pharmacokinetics of fostamatinib, a spleen tyrosine kinase <scp>(SYK)</scp> inhibitor, in healthy human subjects following single and multiple oral dosing in three phase <scp>I</scp> studies

    Pharmacokinetics of fostamatinib, a spleen tyrosine kinase <scp>(SYK)</scp> inhibitor, in healthy human subjects following single and multiple oral dosing in three phase <scp>I</sc... 由 Muhammad Baluom, Elliott B. Grossbard, Tim Mant, David T. W. Lau

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Adverse reactions to acetylcysteine and effects of overdose.

    Adverse reactions to acetylcysteine and effects of overdose. 由 Tim Mant, Joanna Tempowski, G N Volans, J C Talbot

    出版 1984
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses

    Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses 由 P. J. Morrison, Tim Mant, G T Norman, J. A. Robinson, Robert L. Kunka

    出版 1988
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions

    Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions 由 Zeeshan Khan, Ian T. Munday, Ronald M. Jones, Claire Thornton, Tim Mant, Doaa Amin

    出版 1999
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag

    Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag 由 Priska Kaufmann, Kaori Okubo, Shirin Bruderer, Tim Mant, Tetsuhiro Yamada, Jasper Dingemanse, Hideya Mukai

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira <sup>®</sup> in healthy subjects

    Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira <sup>®</sup> in healthy subjects 由 Elizabeth Hyland, Tim Mant, Pantelis Vlachos, Neil Attkins, Martin Ullmann, Sanjeev Roy, Volker Jean Wagner

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma

    Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma 由 Mamidipudi Thirumala Krishna, Anoop Chauhan, Louise Little, K Sampson, Richard J. Hawksworth, Tim Mant, Ratko Djukanović, TH Lee, Stephen T. Holgate

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

    Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A 由 Barbara A. Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone, Bruce M. Ewenstein, Brigitt E. Abbuehl

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants

    Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants 由 Charlotte Maden, David Fairman, Michelle Chalker, Maria José Costa, William A. Fahy, Nadia Garman, Pauline T. Lukey, Tim Mant, Simon Parry, Juliet K. Simpson, Robert J. Slack, Stuart Kendrick, Richard P. Marshall

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

    Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort 由 John Pasi, Toshko Lissitchkov, Vasily Mamonov, Tim Mant, M.A. Timofeeva, Catherine Bagot, Pratima Chowdary, Pencho Georgiev, Liana Gercheva, Kate Madigan, Nguyễn Văn Huy, Qifeng Yu, Baisong Mei, Craig C Benson, Margaret V. Ragni

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

    Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy 由 John Pasi, Savita Rangarajan, Pencho Georgiev, Tim Mant, Michael Desmond Creagh, Toshko Lissitchkov, David Bevan, Steve Austin, C. R. M. Hay, Inga Hegemann, Rashid Kazmi, Pratima Chowdary, Liana Gercheva, Vasily Mamonov, M.A. Timofeeva, Chang-Heok Soh, Pushkal Garg, Akshay Vaishnaw, Akin Akinc, Benny Sørensen, Margaret V. Ragni

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: